close android install prompt
Device showcase
Download the app!
INSTALL
Johns Hopkins Guides
  • Home
  • Favorites
  • Notes
  • Prime PubMed
  • Mobile
  • Browse
PricingLog in
  • REFINE YOUR SEARCH:
  • 55All Results
  • Johns Hopkins ABX GuideJohns Hopkins ABX Guide
  • Johns Hopkins HIV GuideJohns Hopkins HIV Guide
  • Johns Hopkins Diabetes GuideJohns Hopkins Diabetes Guide
  • Johns Hopkins Psychiatry GuideJohns Hopkins Psychiatry Guide
  • Medical NewsMedical News
  • Johns Hopkins Author BiosJohns Hopkins Author Bios
  • Message Center - Hopkins GuidesMessage Center - Hopkins Guides
Casirivimab and Imdevimab
55 results
1 - 55
  • Johns Hopkins ABX GuideCasirivimab and Imdevimab
    • INDICATIONS
      • FDA
    • FORMS
    • References
    • USUAL ADULT DOSING
    • ADULT RENAL DOSING
      • DOSING IN HEMODIALYSIS
      • DOSING IN PERITONEAL DIALYSIS
      • DOSING IN RENAL REPLACEMENT THERAPY
    • PEDIATRIC DOSING
      • USUAL PEDIATRIC DOSING
    • ADVERSE DRUG REACTIONS
      • GENERAL
      • COMMON
    • DRUG INTERACTIONS
    • SPECTRUM
    • PHARMACOLOGY
      • MECHANISM
      • PHARMACOKINETIC PARAMETERS
      • DOSING FOR DECREASED HEPATIC FUNCTION
      • PREGNANCY RISK
      • BREAST FEEDING COMPATIBILITY
    • COMMENTS
  • Johns Hopkins HIV GuideCasirivimab and Imdevimab
    • INDICATIONS
      • FDA
    • References
    • FORMS
    • USUAL ADULT DOSING
    • ADULT RENAL DOSING
      • DOSING IN HEMODIALYSIS
      • DOSING IN PERITONEAL DIALYSIS
      • DOSING IN RENAL REPLACEMENT THERAPY
    • PEDIATRIC DOSING
      • USUAL PEDIATRIC DOSING
    • ADVERSE DRUG REACTIONS
      • GENERAL
      • COMMON
    • DRUG INTERACTIONS
    • SPECTRUM
    • PHARMACOLOGY
      • MECHANISM
      • PHARMACOKINETIC PARAMETERS
      • DOSING FOR DECREASED HEPATIC FUNCTION
      • PREGNANCY RISK
      • BREAST FEEDING COMPATIBILITY
    • COMMENTS
  • Message Center Hopkins GuidesCOVID-19 Update: Therapies and Vaccines
    • COVID-19 Update with Dr. Paul Auwaerter
    • Johns Hopkins HIV GuideCoronavirus COVID-19 (SARS-CoV-2)
      • TREATMENT
        • Antibody-based therapies
        • Prevention
        • Selected Drug Comments
    • Johns Hopkins ABX GuideCoronavirus COVID-19 (SARS-CoV-2)
      • TREATMENT
        • Antibody-based therapies
        • Prevention
        • Selected Drug Comments
    • 1 - 55 of 55 records
    Renew my subscription

    We're glad you have enjoyed Johns Hopkins Guides! As a thank-you for using our site, here's a discounted rate for renewal or upgrade.

    Your free 1 year of online access expired  .

    Want to regain access to Johns Hopkins Guides?

    Log in to Johns Hopkins Guides

    Note: Your username may be different from the email address used to register your account.

    Contact Support

    If you need further assistance, please contact Support.
    • unboundmedicine.com/support
    • support@unboundmedicine.com
    • 610-627-9090(Monday - Friday, 9 AM - 5 PM EST.)
    Password reset sent
    Username sent
    Forgot your username or password?
    Purchase Johns Hopkins Guides
    New to Johns Hopkins Guides?
    Purchase a subscription
    A Johns Hopkins Guides subscription is required to
    Already have an account?Log In
    Purchase Johns Hopkins Guides
    New to Johns Hopkins Guides?
    Purchase a subscription
    Unbound Medicine logo
    • Home
    • Contact Us
    • Privacy / Disclaimer
    • Terms of Service
    • Log in

    © 2000–2022 Unbound Medicine, Inc. All rights reserved

    CONNECT WITH US

    facebooktwitteryoutubeinstagram

    6.0-3450